
Rare blood cancer now detectable using a CRISPR-based test
Acute promyelocytic leukemia (APL) is a rare and aggressive form of leukemia, a cancer that affects blood cells. It is caused by a genetic mutation where two genes, PML and RARA, mistakenly fuse together. The fusion of the two genes leads to the production …